Details for Patent: 9,957,232

✉ Email this page to a colleague

Which drugs does patent 9,957,232 protect, and when does it expire?

Patent 9,957,232 protects STIVARGA and is included in one NDA.

This patent has forty-one patent family members in thirty-seven countries.

Summary for Patent: 9,957,232

Patent landscape, scope, and claims:

Title:	4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenox- y]-N-methylpyridine-2-carboxamide monohydrate
Abstract:	The present invention relates to 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluoropheno- xy]-N-methylpyridine-2-carboxamide monohydrate, to processes for its preparation, to pharmaceutical compositions comprising it and to its use in the control of disorders.
Inventor(s):	Grunenberg; Alfons (Dormagen, DE), Stiehl; Juergen (Sprockhovel, DE), Tenbieg; Katharina (Dortmund, DE), Keil; Birgit (Dusseldorf, DE)
Assignee:	BAYER HEALTHCARE LLC (Whippany, NJ)
Application Number:	12/444,974
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 9,957,232
Patent Claim Types: see list of patent claims	Use; Formulation;
More… ↓ ⤷ Subscribe

Drugs Protected by US Patent 9,957,232

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Bayer Hlthcare	STIVARGA	regorafenib	TABLET;ORAL	203085-001	Sep 27, 2012		RX	Yes	Yes	9,957,232	⤷ Subscribe		Y			⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 9,957,232

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	06021296	Oct 11, 2006

PCT Information
PCT Filed	September 29, 2007	PCT Application Number:	PCT/EP2007/008503
PCT Publication Date:	April 17, 2008	PCT Publication Number:	WO2008/043446

International Family Members for US Patent 9,957,232

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	2097381	⤷ Subscribe	C02097381/01	Switzerland	⤷ Subscribe
Argentina	062927	⤷ Subscribe
Australia	2007306716	⤷ Subscribe
Brazil	PI0719828	⤷ Subscribe
Canada	2666170	⤷ Subscribe
Chile	2007002930	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.